期刊文献+

人脐带沃顿胶间充质干细胞对人外周血T淋巴细胞的免疫调节作用 被引量:2

Immunomodulatory effect of Wharton's jelly-derived mesenchymal stem cells from human umbilical cord on human peripheral blood T lymphocytes
下载PDF
导出
摘要 背景:骨髓源性间充质干细胞具有低免疫原性和免疫调节作用,但有关人脐带沃顿胶间充质干细胞的免疫调节作用及其机制研究较少。目的:观察脐带沃顿胶间充质干细胞对异体外周血T淋巴细胞的免疫调节作用及机制。方法:从人脐带沃顿胶组织块培养中分离出间充质干细胞。将脐带沃顿胶间充质干细胞及脐带沃顿胶间充质干细胞培养上清分别与植物凝集素刺激下的人外周血T淋巴细胞共培养,多功能酶标仪测量脐带沃顿胶间充质干细胞及脐带沃顿胶间充质干细胞培养上清与植物凝集素刺激下的人外周血T淋巴细胞共培养72h后A值;ELISA试剂盒检测培养上清中转化生长因子β1、γ-干扰素的表达。结果与结论:沃顿胶间充质干细胞对植物凝集素刺激下的T淋巴细胞增殖有抑制作用,增殖抑制率为56%(P<0.01),沃顿胶间充质干细胞培养上清对植物凝集素刺激下的T淋巴细胞增殖也具有抑制作用,且这种抑制呈剂量依赖性。含50%沃顿胶间充质干细胞培养上清组和100%培养上清组的增殖抑制率分别为8.3%、27%(P<0.05);沃顿胶间充质干细胞能显著降低T淋巴细胞分泌的γ-干扰素(P<0.05);可分泌转化生长因子β1,沃顿胶间充质干细胞与T淋巴细胞共培养组的转化生长因子β1分泌量低于沃顿胶间充质干细胞单独培养组(P<0.05)。提示沃顿胶间充质干细胞及沃顿胶间充质干细胞培养上清对植物凝集素刺激下的T淋巴细胞增殖均有抑制作用,其作用机制可能与细胞间的接触及抑制T淋巴细胞分泌的γ-干扰素有关。 BACKGROUND:Bone marrow mesenchymal stem cells have low immunogenicity and immunomodulatory effect,but there are seldom reports concerning the immunomodulatory effect of Wharton's jelly-derived mesenchymal stem cells of human umbilical cord and its mechanims.OBJECTIVE:To investigate the immunomodulatory effects and mechanisms of Wharton's jelly-derived mesenchymal stem cells of human umbilical cord on varient peripheral blood T lymphocytes.METHODS:Mesenchymal stem cells were isolateded from Wharton's jelly of human umbilical cord by tissue culture.T lymphocytes from human peripheral blood were stimulated by phytohemagglutinin and co-cultured with umbilical cord Wharton's jelly-derived mesenchymal stem cells and umbilical cord Wharton's jelly-derived mesenchymal stem cells supernatant respectively to measure A value following 72 hours of coculture using multifunctional microplate reader.Expression of cytokines including transforming growth factor-beta 1(TGF-β1) and interferon-γ(IFN-γ) was evaluated by enzyme-labeled immunosorbent assay.RESULTS AND CONCLUSION:Wharton's jelly-derived mesenchymal stem cells could inhibite the proliferation of T lymphocytes induced by phytohemagglutinin.The proliferation inhibition rate was 56%(P〈 0.01).Wharton's jelly-derived mesenchymal stem cells supernatant also had inhibitory effects on proliferation of T lymphocytes induced by phytohemagglutinin,in a dose-dependent fashion.The proliferation inhibition rates were 8.3% and 27% respectively in the 50% Wharton's jelly-derived mesenchymal stem cells supernatant and 100% Wharton's jelly-derived mesenchymal stem cells supernatant groups(P〈 0.05).Wharton's jelly-derived mesenchymal stem cells significantly decreased γ-interferon secrted from T-lymphocytes(P 0.05).The secretion of TGF-β1 was lower in the coculture of Wharton's jelly-derived mesenchymal stem cells and T lymphocytes group than Wharton's jelly-derived mesenchymal stem cells alone group(P 〈0.05).These indicate
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2010年第14期2485-2491,共7页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 郑州大学211三期建设项目"干细胞基础与临床研究" 河南省科技厅09科技发展计划(092102310250) 郑州市二七区科技局社会发展项目(20095157) 江苏省干细胞与生物治疗公共技术服务平台(BM2008146)~~
  • 相关文献

参考文献1

二级参考文献9

  • 1Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science,1999, 284:143-147. 被引量:1
  • 2Devine SM, Hoffman R. Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Cur Opin Hematol, 2000, 7:358-363. 被引量:1
  • 3Majumdar MK, Thiede MA, Mosca JD, et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol, 1998, 176: 57-66. 被引量:1
  • 4Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells, 2001, 19: 180-192. 被引量:1
  • 5Shibano K, Watanabe J,Iwamoto M, et al. Culture of stromal cells derived from medullary cavity of human longbone in the presence of 1,25-dihydroxyvitamin D3,recombinant human bone morphogenetic protein-2, or ipriflavone. Bone, 1998, 22: 251-258. 被引量:1
  • 6Le Blanc K, Tammik C, Rosendahl K, et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol,2003, 31: 890-896. 被引量:1
  • 7Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol,2002, 30:42 -48. 被引量:1
  • 8Le Blanc K, Tammik L, Sundberg B, et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol, 2003, 57:11-20. 被引量:1
  • 9Farida Djouad, Plence P, Bony C, et al. Immunosuppressire effect of mesenchymal stem cells favors tumor growthin allogeneic animals. Blood,2003, 102:3837-3844. 被引量:1

共引文献1

同被引文献21

  • 1Liang L , Dong C , Chen X , et al. Human umbilical cordmesenchymal stem cells ameliorate mice trinitrobenzenesulfonic acid ( TNBS ) -induced colitis [J] . Cell T ra n sp lan t,2 0 1 1 ,2 0 ( 9 ) ;1395-1408. 被引量:1
  • 2Duijvestein M , Vos A C , Roelofs H , et al. Autologousbone marrow-derived mesenchymal stromal cell treatmentfor refractory luminal Crohns d isease; results of a phase Istudy[J] . G u t,2 0 1 0,5 9 ( 1 2 ) ; 1662-1669. 被引量:1
  • 3Strober X , Fuss I , Mannon P. The fundamental basis ofinflammatory bowel disease [J] . J C /n Invest,2 0 0 7 , 117⑶ ;514-521. 被引量:1
  • 4Fujino S , Andoh A , Bamba S , et al. Increased expressionof interleukin 17 in inflammatory bowel disease [J]. G u t,2 0 0 3 , 5 2 ⑴ ;65-70. 被引量:1
  • 5Nielsen O H , Kirman I , Rudiger N , et al. Upregulation ofinterleukin-12 and -17 in active inflammatory bowel d isease[J] . Scand J G astroenterol,2 0 0 3 ,3 8 ( 2 ) ; 180-185. 被引量:1
  • 6Marwaha A K , Leung N J, McMurchy A N , et al. TH17cells in autoimmunity and imm unodeficiency; protective orpathogenic- [J] . Front Im m unol,2 0 1 2 , 3 ; 129. 被引量:1
  • 7Tsang M , Friesel R , Kudoh T , et al. Identification ofS ef, a novel modulator of FGF signalling [J]. Nat CellB iol,2 0 0 2,4 ( 2 ) ; 165-169. 被引量:1
  • 8R o n g Z , Wang A , Li Z , et al. I L - 1 7 R D ( S e f o r I L -17RLM) interacts with IL-17 receptor and mediates IL-17signaling[J] . Cell R e s,2 0 0 9 ,1 9 (2 ) ;208-215. 被引量:1
  • 9Dominici M , Le Blanc K , Mueller I , et al. Minimal criteriafor defining mu/iiDoent mesenchymal stromal cells. theinternational society for cellular therapy position statement[J] . Cytothem py,2 0 0 6 , 8 ( 4 ) ;315-317. 被引量:1
  • 10Wirtz S , Neufert C , Weigmann B , et al. Chemically inducedmouse models of intestinal inflammation [J] . NatProtoc, 2 0 0 7 ,2 ( 3 ) ;541-546. 被引量:1

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部